Potential kidney protection with liraglutide and semaglutide: Exploratory mediation analysis

Abstract

Our results suggest that HbA1c and systolic BP may moderately mediate kidney benefits of liraglutide and semaglutide, with all other variables having a small to no effect. Potential kidney benefits may be driven by other mediators or potentially by direct mechanisms.